Skip to content
The Policy VaultThe Policy Vault

pazopanib — Medica

Gastrointestinal stromal tumor

Initial criteria

  • age ≥ 18 years
  • Patient has succinate dehydrogenase (SDH)-deficient GIST OR has tried imatinib, sunitinib, Stivarga (regorafenib), and Qinlock (ripretinib)

Approval duration

1 year